What's happening
This bill lowers the maximum monthly out-of-pocket cost for insulin prescriptions in New York to thirty dollars.
Why it matters
Significantly reduces financial burden for insulin users. By lowering the cap from $100 to $30 per month, this bill could make insulin dramatically more affordable for the many New Yorkers with diabetes who rely on it regularly, potentially freeing up income for other basic needs.
Applies regardless of insurance plan details. The new $30 cap is enforced regardless of the type or amount of insulin needed or the specifics of a person’s insurance plan (such as deductibles, copays, or coinsurance), ensuring broad protection against high costs.
Immediate effect on new and renewed policies. The law will apply to any health insurance policy issued or renewed after January 1, 2022, meaning the cost savings for consumers could be realized quickly and widely across the state.
Addresses public health equity. Lowering out-of-pocket costs for essential medication like insulin may help reduce disparities in diabetes care, particularly benefitting lower-income and uninsured or underinsured populations who are often most impacted by high drug prices.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Insured people who use insulin
The bill would lower their out-of-pocket cap for covered prescription insulin from $100 to $30 per thirty-day supply, regardless of the amount or type needed or other cost-sharing requirements.
Health insurers
The bill would require the lower cap for covered policies and contracts issued or renewed on or after January 1, 2022.
State insurance regulators
The bill would lower the insulin cost-sharing ceiling in the coverage provisions they oversee while retaining the superintendent’s role in determining appropriate deductibles and coinsurance.
Headline styles
Cap Insulin Copays at $30
Plain English, a few words. Used as the page title.
Sponsors
2 Co-sponsors
History
- Held for consideration in insurance
- Referred to insurance
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Cap Insulin Out-of-Pocket Costs
In Assembly Committee · Insurance · Sponsor Gustavo Rivera
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
2383
2021-2022 Regular Sessions
IN ASSEMBLY
January 19, 2021
Introduced by M. of A. NIOU -- read once and referred to the Committee on Insurance
AN ACT to amend the insurance law, in relation to capping cost sharing for insulin
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subparagraph (B) of paragraph 15-a of subsection (i) of section 3216 of the insurance law, as amended by section 1 of part DDD of chapter 56 of the laws of 2020, is amended to read as follows:
(B) Such coverage may be subject to annual deductibles and coinsurance as may be deemed appropriate by the superintendent and as are consistent with those established for other benefits within a given policy; provided however, the total amount that a covered person is required to pay out of pocket for covered prescription insulin drugs shall be capped at an amount not to exceed [one hundred] thirty dollars per thirty-day supply, regardless of the amount or type of insulin needed to fill such covered person's prescription and regardless of the insured's deductible, copayment, coinsurance or any other cost sharing requirement.
§ 2. Subparagraph (B) of paragraph 7 of subsection (k) of section 3221 of the insurance law, as amended by section 2 of part DDD of chapter 56 of the laws of 2020, is amended to read as follows:
(B) Such coverage may be subject to annual deductibles and coinsurance as may be deemed appropriate by the superintendent and as are consistent with those established for other benefits within a given policy; provided however, the total amount that a covered person is required to pay out of pocket for covered prescription insulin drugs shall be capped at an amount not to exceed [one hundred] thirty dollars per thirty-day supply, regardless of the amount or type of insulin needed to fill such covered person's prescription and regardless of the insured's deductible, copayment, coinsurance or any other cost sharing requirement.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD04974-01-1
A. 2383 2
§ 3. Paragraph 2 of subsection (u) of section 4303 of the insurance law, as amended by section 3 of part DDD of chapter 56 of the laws of 2020, is amended to read as follows:
(2) Such coverage may be subject to annual deductibles and coinsurance as may be deemed appropriate by the superintendent and as are consistent with those established for other benefits within a given policy; provided however, the total amount that a covered person is required to pay out of pocket for covered prescription insulin drugs shall be capped at an amount not to exceed [one hundred] thirty dollars per thirty-day supply, regardless of the amount or type of insulin needed to fill such covered person's prescription and regardless of the insured's deductible, copayment, coinsurance or any other cost sharing requirement.
§ 4. This act shall take effect immediately and shall apply to any policy or contract issued or renewed on or after January 1, 2022.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.